1) https://www.ncbi.nlm.nih.gov/pubmed/?term=11911601
Assessment of frequencies of lifestyle factors and polymorphisms of drug-
metabolizing enzymes (NAT2, CYP2E1) in human hepatocellular carcinoma (HCC)
patients in a department of surgical medicine--a pilot investigation.
Int J Clin Pharmacol Ther. 2002 Mar;40(3):120-4.
2) https://www.ncbi.nlm.nih.gov/pubmed/?term=11220663
IARC Sci Publ. 2001;154:241-4.
Hepatocellular carcinoma: susceptibility markers.
email: [email protected]/* */
Thank you!!
